These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1100135)
1. Randomization and the analysis of variance. White RF Biometrics; 1975 Jun; 31(2):555-71. PubMed ID: 1100135 [TBL] [Abstract][Full Text] [Related]
2. Randomization and efficiency in Zelen's single-consent design. Matts J; McHugh R Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173 [TBL] [Abstract][Full Text] [Related]
3. On design considerations and randomization-based inference for community intervention trials. Gail MH; Mark SD; Carroll RJ; Green SB; Pee D Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140 [TBL] [Abstract][Full Text] [Related]
4. A Bayesian analysis of the two-period crossover design for clinical trials. Grieve AP Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262 [TBL] [Abstract][Full Text] [Related]
5. Statistical design of quantitative mass spectrometry-based proteomic experiments. Oberg AL; Vitek O J Proteome Res; 2009 May; 8(5):2144-56. PubMed ID: 19222236 [TBL] [Abstract][Full Text] [Related]
6. Designs for slope ratio assays. Buonaccorsi JP Biometrics; 1986 Dec; 42(4):875-82. PubMed ID: 3814728 [TBL] [Abstract][Full Text] [Related]
7. Variance identification and efficiency analysis in randomized experiments under the matched-pair design. Imai K Stat Med; 2008 Oct; 27(24):4857-73. PubMed ID: 18618425 [TBL] [Abstract][Full Text] [Related]
8. Restricted randomization designs in clinical trials. Simon R Biometrics; 1979 Jun; 35(2):503-12. PubMed ID: 486683 [TBL] [Abstract][Full Text] [Related]
10. A mixed-effects model for categorical data. Beitler PJ; Landis JR Biometrics; 1985 Dec; 41(4):991-1000. PubMed ID: 3830263 [TBL] [Abstract][Full Text] [Related]
11. On variance estimation in crossover designs. Kunert J Biometrics; 1987 Dec; 43(4):833-45. PubMed ID: 3427168 [TBL] [Abstract][Full Text] [Related]
12. Patient heterogeneity in clinical trials. Simon R Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777 [TBL] [Abstract][Full Text] [Related]
13. Sample sizes in the multivariate analysis of repeated measurements. Vonesh EF; Schork MA Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293 [TBL] [Abstract][Full Text] [Related]
14. Modelling and design of cross-over trials. Jones B; Donev AN Stat Med; 1996 Jul; 15(13):1435-46. PubMed ID: 8841653 [TBL] [Abstract][Full Text] [Related]
15. Optimal multivariate matching before randomization. Greevy R; Lu B; Silber JH; Rosenbaum P Biostatistics; 2004 Apr; 5(2):263-75. PubMed ID: 15054030 [TBL] [Abstract][Full Text] [Related]
16. The relative efficiency of Zelen's prerandomization design for clinical trials. Anbar D Biometrics; 1983 Sep; 39(3):711-8. PubMed ID: 6652204 [TBL] [Abstract][Full Text] [Related]
17. Analysing sequential events in clinical trials. Salter A; Raab G; Day S Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216 [TBL] [Abstract][Full Text] [Related]
18. Experimental design in chemistry: A tutorial. Leardi R Anal Chim Acta; 2009 Oct; 652(1-2):161-72. PubMed ID: 19786177 [TBL] [Abstract][Full Text] [Related]
19. General purpose of research designs. Jang R Am J Hosp Pharm; 1980 Mar; 37(3):398-403. PubMed ID: 7369224 [TBL] [Abstract][Full Text] [Related]
20. [Randomization for controlled therapeutic trials]. Schemper M Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]